Invention Grant
- Patent Title: Compound having chiral spirobiindane skeleton and preparation method therefor
-
Application No.: US16060424Application Date: 2016-12-12
-
Publication No.: US11325875B2Publication Date: 2022-05-10
- Inventor: Kuiling Ding , Yuxi Cao , Zhiyao Zheng , Qinglei Chong , Zheng Wang
- Applicant: ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. , SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES
- Applicant Address: CN Taizhou; CN Shanghai
- Assignee: ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD.,SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES
- Current Assignee: ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD.,SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES
- Current Assignee Address: CN Taizhou; CN Shanghai
- Agency: Novick, Kim & Lee, PLLC
- Agent Allen Xue
- Priority: CN201510974151.1 20151222
- International Application: PCT/CN2016/109383 WO 20161212
- International Announcement: WO2017/107789 WO 20170629
- Main IPC: C07C13/72
- IPC: C07C13/72 ; B01J31/22 ; C07C39/17 ; C07C43/21 ; C07C43/225 ; C07F9/6571 ; C07B53/00 ; C07C231/12 ; C07C233/51

Abstract:
Chiral spirobiindane skeleton compound and preparation method thereof is disclosed in the present invention. The spirobiindane skeleton compound of the present invention having the structure formula of I or I′; the preparation method for synthesizing the spirobiindane skeleton compound of the present invention comprising the following steps: in the presence of solvent and catalysts, the structure formula compound III reacted through intramolecular Friedel-Crafts reaction to obtain the compound of formula I; the catalyst is a Browsteric acidor Lewis acid. The preparation method of chiral fused spirobiindane skeleton compound of the present invention does not need to adopt chiral starting materials or chiral resolving agents, does not require chiral resolving steps, is simple in method, is simple in post-treatment, and is economic and environment friendly. High product yield, high product optical purity and chemical purity. The catalyst for the asymmetric reaction is obtained from the chiral spirobiindane skeleton ligand of the present invention, under the catalytic reagent of transition metal, the catalyzed hydrogenation reaction can arrive at a remarkable catalytic effect with a product yield of >99%, and a product ee value of up to >99%.
Public/Granted literature
- US20180370876A1 Compound having chiral spirobiindane skeleton and preparation method therefor Public/Granted day:2018-12-27
Information query